SEC Form 4 · accession 0001017491-16-000123
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Troupin
Officer — SVP, Chief Medical Officer
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 15, 2016 | A | 43,918 | — | A | 43,918 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $1.11 | Mar 15, 2016 | A | 200,000 | A | — | Mar 14, 2026 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Award of 43,918 Restricted Stock Units ("RSUs") under the Issuer's 2012 Stock Long Term Incentive Plan with the underlying shares vesting fully on February 15, 2017, subject to the Reporting Person's continued employment or service to the Issuer through such date.
- F2Not applicable.
- F3This option shall vest with respect to one-fourth of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next three years so the option will be fully vested as of 3/15/2020, subject to the Reporting Person's continued employment or service to the Issuer through such date.